ACURA PHARMACEUTICALS, INC Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amendment to the Amended License, Development and Commercialization Agreement is made and entered into as of February 28, 2022 by the Registrant and between Abuse Deterrent...
License Agreements
ACURA PHARMACEUTICALS, INC
Pharmaceuticals
NY
2023
Amendment #2 to the License, Development and Commercialization Agreement is made and entered into as of June 17, 2021 by the Registrant and between Abuse Deterrent Pharma, LLC
License Agreements
ACURA PHARMACEUTICALS, INC
Pharmaceuticals
NY
2023
Amended License, Development and Commercialization Agreement is made and entered into as of October 16, 2020 by the Registrant and between Abuse Deterrent Pharmaceuticals, LLC
License Agreements
ACURA PHARMACEUTICALS, INC
Pharmaceuticals
NY
2021
License, Development and Commercialization Agreement is made and entered into as of June 28, 2019 by the Registrant and between Abuse Deterrent Pharmaceuticals, LLC
License Agreements
ACURA PHARMACEUTICALS, INC
Pharmaceuticals
NY
2020
License, Commercialization and Option Agreement is made and entered into as of March 16, 2017 by and between MainPointe Pharmaceuticals, LLC
License Agreements
ACURA PHARMACEUTICALS, INC
Pharmaceuticals
NY
2018
LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN ACURA PHARMACEUTICALS, INC. AND KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
License Agreements
ACURA PHARMACEUTICALS, INC
Pharmaceuticals
2007